$1.03
-0.07-5.91%
Ultimo aggiornamento: 12:35 PM
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su TScan Therapeutics Inc (NASDAQ:TCRX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 1.68M a 1.74M. Questo rappresenta il 3.73% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 569.46K azioni scambiate al giorno, ci vorrebbero 3.06 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.74M
Vendite allo scoperto %
3.73%
Giorni di copertura
3.06
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. Commo | 10/31/2025 | 11/11/2025 | 3.73% | 46,673,482 | 1,742,176 | 569,461 | 3.06 | |
TCRX | TScan Therapeutics, Inc. Commo | 10/15/2025 | 10/24/2025 | 3.59% | 46,673,482 | 1,675,616 | 959,807 | 1.75 | |
TCRX | TScan Therapeutics, Inc. Commo | 09/30/2025 | 10/09/2025 | 3.36% | 46,673,482 | 1,567,792 | 277,361 | 5.65 | |
TCRX | TScan Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 3.69% | 46,673,482 | 1,722,543 | 238,606 | 7.22 | |
TCRX | TScan Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 3.67% | 46,673,482 | 1,711,155 | 201,892 | 8.48 | |
TCRX | TScan Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 3.97% | 46,673,482 | 1,853,155 | 229,311 | 8.08 | |
TCRX | TScan Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 3.69% | 46,516,116 | 1,717,845 | 303,486 | 5.66 | |
TCRX | TScan Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 3.94% | 46,516,116 | 1,833,410 | 327,431 | 5.6 | |
TCRX | TScan Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 4.25% | 46,516,116 | 1,978,866 | 928,714 | 2.13 | |
TCRX | TScan Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 4.88% | 46,516,116 | 2,268,054 | 401,977 | 5.64 | |
TCRX | TScan Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 4.33% | 46,516,116 | 2,014,752 | 1,264,002 | 1.59 | |
TCRX | TScan Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 4.95% | 46,516,116 | 2,303,027 | 258,986 | 8.89 | |
TCRX | TScan Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 3.83% | 46,770,959 | 1,793,660 | 519,046 | 3.46 | |
TCRX | TScan Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | 3.88% | 46,770,959 | 1,816,555 | 472,348 | 3.85 | |
TCRX | TScan Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 4.33% | 46,770,959 | 2,025,238 | 580,834 | 3.49 | |
TCRX | TScan Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 4.06% | 46,770,959 | 1,900,134 | 321,717 | 5.91 | |
TCRX | TScan Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 4.76% | 46,770,959 | 2,225,112 | 625,050 | 3.56 | |
TCRX | TScan Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 4.79% | 41,794,433 | 2,002,749 | 252,583 | 7.93 | |
TCRX | TScan Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 4.35% | 41,794,433 | 1,818,854 | 204,704 | 8.89 | |
TCRX | TScan Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 4.78% | 41,794,433 | 1,998,350 | 389,298 | 5.13 | |
TCRX | TScan Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 6.52% | 38,659,637 | 2,519,323 | 687,562 | 3.66 | |
TCRX | TScan Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 6.07% | 38,659,637 | 2,346,815 | 665,922 | 3.52 | |
TCRX | TScan Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 6.00% | 38,659,637 | 2,317,690 | 170,070 | 13.63 | |
TCRX | TScan Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 5.94% | 38,659,637 | 2,295,860 | 339,886 | 6.75 | |
TCRX | TScan Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 5.66% | 38,262,913 | 2,164,450 | 156,955 | 13.79 | |
TCRX | TScan Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 5.86% | 38,262,913 | 2,244,117 | 172,281 | 13.03 | |
TCRX | TScan Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 5.40% | 38,262,913 | 2,065,654 | 246,103 | 8.39 | |
TCRX | TScan Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 4.70% | 38,262,913 | 1,796,710 | 194,276 | 9.25 | |
TCRX | TScan Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 3.57% | 38,262,913 | 1,367,150 | 206,296 | 6.63 | |
TCRX | TScan Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 3.09% | 38,151,848 | 1,178,977 | 218,083 | 5.41 | |
TCRX | TScan Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 2.68% | 38,151,848 | 1,021,413 | 379,472 | 2.69 | |
TCRX | TScan Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 1.59% | 38,151,848 | 608,202 | 1,087,002 | 1 | |
TCRX | TScan Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 1.34% | 38,151,848 | 512,432 | 146,023 | 3.51 | |
TCRX | TScan Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 1.27% | 38,151,848 | 482,830 | 212,113 | 2.28 | |
TCRX | TScan Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 1.00% | 38,151,848 | 381,761 | 175,515 | 2.18 | |
TCRX | TScan Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 1.04% | 38,151,848 | 397,970 | 299,234 | 1.33 | |
TCRX | TScan Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 1.10% | 38,151,848 | 419,685 | 120,251 | 3.49 | |
TCRX | TScan Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 0.76% | 28,778,870 | 219,413 | 294,771 | 1 | |
TCRX | TScan Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 0.49% | 38,196,456 | 188,336 | 122,963 | 1.53 | |
TCRX | TScan Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 0.49% | 38,196,456 | 187,726 | 280,092 | 1 | |
TCRX | TScan Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 0.64% | 38,138,940 | 243,593 | 82,389 | 2.96 | |
TCRX | TScan Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 0.68% | 38,138,940 | 260,257 | 181,811 | 1.43 | |
TCRX | TScan Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 0.80% | 38,138,940 | 304,733 | 163,207 | 1.87 | |
TCRX | TScan Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 0.93% | 38,138,940 | 354,698 | 173,515 | 2.04 | |
TCRX | TScan Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 0.98% | 38,138,940 | 373,278 | 148,766 | 2.51 | |
TCRX | TScan Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 1.09% | 38,138,940 | 416,028 | 78,757 | 5.28 |
In cerca di azioni più vendute allo scoperto?